Literature DB >> 26595732

Mechanisms of Chronic Obstructive Pulmonary Disease Exacerbations.

Jadwiga A Wedzicha1.   

Abstract

Chronic obstructive pulmonary disease (COPD) exacerbations are important events that contribute to worsening health status, disease progression, and mortality. They are mainly triggered by respiratory viruses (especially rhinovirus, the cause of the common cold), but airway bacteria are also involved in their pathogenesis. Exacerbations are associated with both airway and systemic inflammation and, this is mainly neutrophilic in origin. Some patients are especially prone to develop exacerbations, and these have been identified as a high-risk group with increased airway inflammation and greater disease progression. Management of acute exacerbations involves therapy with oral corticosteroids and/or antibiotics, and new therapies are needed. A number of interventions may prevent exacerbations, including vaccination, long-acting bronchodilators, antiinflammatory agents, and long-term antibiotic therapy. Understanding of the pathophysiological mechanisms of COPD exacerbations is important to develop novel therapies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26595732     DOI: 10.1513/AnnalsATS.201507-427AW

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  9 in total

1.  Early Endotyping: A Chance for Intervention in Chronic Obstructive Pulmonary Disease.

Authors:  Hans Petersen; Rodrigo Vazquez Guillamet; Paula Meek; Akshay Sood; Yohannes Tesfaigzi
Journal:  Am J Respir Cell Mol Biol       Date:  2018-07       Impact factor: 6.914

2.  p38 Inhibition Ameliorates Inspiratory Resistive Breathing-Induced Pulmonary Inflammation.

Authors:  Dimitrios Toumpanakis; Vyronia Vassilakopoulou; Eleftheria Mizi; Athanasia Chatzianastasiou; Konstantinos Loverdos; Ioanna Vraila; Fotis Perlikos; Dionysios Tsoukalas; Charoula-Eleni Giannakopoulou; Adamantia Sotiriou; Maria Dettoraki; Vassiliki Karavana; Theodoros Vassilakopoulos
Journal:  Inflammation       Date:  2018-10       Impact factor: 4.092

3.  Increased Small Intestinal Permeability during Severe Acute Exacerbations of COPD.

Authors:  Roy T M Sprooten; Kaatje Lenaerts; Dionne C W Braeken; Ilvy Grimbergen; Erica P Rutten; Emiel F M Wouters; Gernot G U Rohde
Journal:  Respiration       Date:  2018-01-25       Impact factor: 3.580

4.  Differential DNA methylation marks and gene comethylation of COPD in African-Americans with COPD exacerbations.

Authors:  Robert Busch; Weiliang Qiu; Jessica Lasky-Su; Jarrett Morrow; Gerard Criner; Dawn DeMeo
Journal:  Respir Res       Date:  2016-11-05

5.  Characterization of TLR-induced inflammatory responses in COPD and control lung tissue explants.

Authors:  Anna Pomerenke; Simon R Lea; Sarah Herrick; Mark A Lindsay; Dave Singh
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-09-29

Review 6.  Management of airway mucus hypersecretion in chronic airway inflammatory disease: Chinese expert consensus (English edition).

Authors:  Yongchun Shen; Shaoguang Huang; Jian Kang; Jiangtao Lin; Kefang Lai; Yongchang Sun; Wei Xiao; Lan Yang; Wanzhen Yao; Shaoxi Cai; Kewu Huang; Fuqiang Wen
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-01-30

7.  Prediction of severe exacerbations and mortality in COPD: the role of exacerbation history and inspiratory capacity/total lung capacity ratio.

Authors:  João Cardoso; Ricardo Coelho; Carla Rocha; Constança Coelho; Luísa Semedo; A Bugalho Almeida
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-04-05

Review 8.  Immunostimulants in respiratory diseases: focus on Pidotimod.

Authors:  Francesca Puggioni; Magna Alves-Correia; Manar-Farouk Mohamed; Niccolò Stomeo; Riccardo Mager; Massimiliano Marinoni; Francesca Racca; Giovanni Paoletti; Gilda Varricchi; Veronica Giorgis; Giovanni Melioli; Giorgio Walter Canonica; Enrico Heffler
Journal:  Multidiscip Respir Med       Date:  2019-11-04

9.  Chronic obstructive pulmonary disease exacerbations and progression in relation to ambient air pollutants exposure.

Authors:  Miglena Doneva; Guenka Petrova; Daniela Petrova; Maria Kamusheva; Valentina Petkova; Konstantin Tachkov; Ventsislava Pencheva; Ognyan Georgiev
Journal:  J Thorac Dis       Date:  2019-06       Impact factor: 2.895

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.